Go beyond in biopharmaceutical characterization

Importance of the Topic

Biopharmaceutical drugs are becoming increasingly complex, demanding robust analytical methods for detailed structural characterization to ensure therapeutic efficacy and patient safety.

Objectives and Article Overview

This paper introduces the Thermo Scientific Orbitrap Eclipse Tribrid mass spectrometer and reviews its hardware and software innovations designed to advance biopharmaceutical characterization workflows.

Methodology and Instrumentation

The Orbitrap Eclipse Tribrid uses a high-performance quadrupole, an ultra-high-field Orbitrap analyzer, and a dual-pressure linear ion trap with extended high-pressure cell. Key capabilities include:

• High-mass range detection to m/z 8000 for native and denatured proteins (HMRn)
• Variable IRM pressure for improved ion trapping efficiency
• Enhanced vacuum in the C-trap and Orbitrap under higher gas pressures
• Optional Proton Transfer Charge Reduction (PTCR) to simplify spectra
• Multiple fragmentation modes (HCD, CID, ETD, EThcD, UVPD)
• FAIMS Pro interface for gas-phase ion selection

Main Results and Discussion

• PTCR significantly reduced spectral complexity, enabling clear deconvolution of heterogeneous cytokine–Fc fusion proteins.
• ETD combined with PTCR increased large product ion detection by over 1000%, achieving up to 63% sequence coverage for mAb subunits.
• Native MS of trastuzumab achieved baseline resolution of common glycoforms with mass accuracy within 7 ppm.
• Native top-down fragmentation using combined ETD, EThcD, UVPD, and HCD yielded 43% sequence coverage while preserving noncovalent interactions.
• FAIMS Pro interface enabled rapid separation and characterization of mAb heavy and light chains in under five minutes, achieving up to 65% sequence coverage.

Benefits and Practical Applications

• Deep structural insight into complex therapeutics for confident critical quality attribute assessment.
• Simplified operation and predefined workflows reduce development time.
• High throughput supports early discovery and regulatory compliance.

Future Trends and Opportunities

Integration of AI-driven method optimization, expanded mass range technology, and novel dissociation strategies will further accelerate in-depth characterization of next-generation biologics, including multispecific formats and antibody–drug conjugates.

Conclusion

The Orbitrap Eclipse Tribrid mass spectrometer offers a comprehensive and user-friendly platform for advanced biotherapeutic characterization, enabling unparalleled insights into protein structure and heterogeneity.

References

• McLuckey SA, Stephenson JL Jr. Ion/Ion Chemistry of High-mass Multiply Charged Ions. Mass Spectrom Rev. 1998;17(6):369–407.